SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001535384-20-000004
Filing Date
2020-12-29
Accepted
2020-12-29 12:14:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 KTA NBSE SC 13G kta-nbse-13g.htm SC 13G/A 71399
2 KTA NBSE SC 13G ktanbse13g_2.jpg GRAPHIC 21028
3 KTA NBSE SC 13G ktanbse13g_1.jpg GRAPHIC 1074
  Complete submission text file 0001535384-20-000004.txt   103913
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Subject) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-82720 | Film No.: 201421375
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1825B KRAMER LANE SUITE 200 AUSTIN TX 78758
Business Address 1825B KRAMER LANE SUITE 200 AUSTIN TX 78758 512-439-8140
Kershner Trading Americas,LLC (Filed by) CIK: 0001535384 (see all company filings)

IRS No.: 262018299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A